Drug
Silodosin
Silodosin: highest development phase Post-Market, developed by Recordati. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Recordati
Trials
| Drug | Phase | Indication |
|---|---|---|
| Silodosin NCT01757769 | Post-Market | Benign Prostatic Hyperplasia |
| Silodosin NCT00359905 | Phase 3 | Benign Prostatic Hyperplasia |
Latest
No recent events.
Follow Silodosin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.